Latest Announcements

Blue Dart Express Limited has announced 'Rakhi Express Offers' on Domestic and International Shipments, providing special flat rates and discounts on shipments weighing up to 3 kg. The offer is valid from 27 July to 28 August 2026 and is available across Blue Dart-DHL retail stores and Franchisee Collection Centres.

Vaibhav Global Limited has reported Q1 FY27 earnings, with revenue growth of 12.7% YoY, EBITDA growth of 37% YoY, and PAT growth of 50% YoY. The company has seen a strong improvement in EBITDA margin to 11%.

Laffans Petrochemicals Ltd. has announced its unaudited financial results for the quarter ended 30th June, 2026. The company's revenue from operations was Rs. 112.00 lacs, with a total revenue of Rs. 714.44 lacs. The net profit for the period after tax was Rs. 497.17 lacs. The company's basic and diluted EPS before extraordinary items was Rs. 6.21.

Happy Forgings Limited has announced its Q1 FY27 earnings, with revenue reaching Rs.449 crores and PAT standing at Rs.91 crores, marking the highest ever quarterly revenue and profitability with growth of 27.0% and 39.2% respectively.

Godrej Consumer Products Ltd has appointed Aasif Malbari as Managing Director & CEO, effective immediately, succeeding Sudhir Sitapati. Aasif has three decades of experience in FMCG and auto industries, and has led the transformation of GCPL's Africa business, growing EBITDA margins from ~9% in FY24 to ~15% in FY26.

Godrej Consumer Products Limited has appointed Aasif Malbari as Managing Director & CEO, effective immediately. Aasif has three decades of experience in the FMCG and auto industries, and has delivered an outstanding transformation of GCPL's Africa business.

Deepak Nitrite Ltd has announced its Q1 FY 2027 earnings, with consolidated revenue from operations at INR 2,592 crore, a 35% year-on-year improvement and a 22% growth sequentially. EBITDA reached an all-time high of INR 554 crore, growing 159% year-on-year and 45% sequentially, while EBITDA margins expanded to 21% compared with 11% last year and 18% sequentially.

Grasim Industries Ltd has commenced commercial production of its CPVC Resin Plant at Vilayat, Gujarat, in collaboration with Lubrizol Advanced Materials India Private Limited, marking a significant milestone in its downstream chlor-alkali derivatives portfolio and domestic manufacturing capabilities under the 'Make in India' initiative.

Firstsource Solutions Limited has partnered with Cresta, a customer experience AI platform, to deliver an integrated AI technology solution for enterprise customer experience transformation.

Grasim Industries Limited has commenced commercial production of its CPVC Resin Plant at Vilayat, Gujarat, in collaboration with Lubrizol Advanced Materials India Private Limited. The plant has a planned capacity of approximately 50,000 metric tonnes per annum, marking a significant milestone in the company's strategy to strengthen its downstream chlor-alkali derivatives portfolio and enhance domestic manufacturing capabilities under the 'Make in India' initiative.

Firstsource Solutions Ltd, a global intelligence partner, has partnered with Cresta, a leading customer experience AI platform, to deliver an integrated AI technology solution for enterprise customer experience transformation.

Deepak Nitrite Limited has submitted the transcript of its Q1 FY27 earnings conference call, which was held on August 6, 2026. The company reported record revenues, EBITDA, profit before tax, and profit after tax. The strong performance reflects the benefits of its manufacturing model and the addition of new molecules to its product basket.

Happy Forgings Ltd has announced its Q1 FY27 earnings, with revenue reaching Rs.449 crores and PAT standing at Rs.91 crores, marking a 27.0% and 39.2% year-on-year growth respectively. The company has delivered industry-leading margins, with EBITDA margin expanding by 275 basis points to 31.3% and PAT margin expanding by 178 basis points to 20.4%. The company has also successfully negotiated price revisions with OEMs to mitigate inflationary pressures.

Ritco Logistics Limited has secured new contracts worth INR 342 Crores in the transportation and warehousing business verticals, including a major contract from HPCL Rajasthan Refinery Limited (HRRL) and a warehousing contract from OPAL (ONGC Petro additions Limited).

Cubical Financial Services Ltd announced its unaudited financial results for the quarter ended 30th June, 2026. The company reported a net profit of Rs. 23.47 lakhs, a 6.91% increase from the same quarter last year. The earnings per share (EPS) was Rs. 0.04, a 300% increase from the same quarter last year. The company's financial results were approved and adopted in the meeting of Board of Directors held on 11th August, 2026.

Chennai Meenakshi Multispeciality Hospital Ltd. has announced the outcome of its board meeting held on August 11, 2026. The board has approved the appointment of four new directors, including Dr. Thanigai Vendan Moorrthy as Chief Executive Officer and three independent directors. The board has also reconstituted the audit committee and stakeholders relationship committee. The unaudited financial results for the quarter ended June 30, 2026, along with the limited review report, are enclosed as annexure A.

Viyash Scientific Ltd announces Q1 FY 2026-27 unaudited standalone and consolidated financial results, with revenues up 19.5%, EBITDA up 59.2%, and PAT up 114.9%. The company will conduct an earnings call on August 12, 2026.

Ritco Logistics Ltd secured new contracts worth nearly INR 342 Crores in Transportation and Warehousing, further strengthening its business portfolio and reinforcing its position as an integrated logistics solutions provider.

RITES Ltd's Q1 FY27 unaudited financial results show a 9-10% YoY growth in revenue and an 8% growth in bottom line. The company is upbeat about the performance, but needs to improve execution in the coming quarters to meet FY guidance.

Bharat Parenterals Ltd's wholly owned subsidiary Varenyam Biolifesciences Private Ltd is upgrading its upcoming Savli manufacturing facility to offer biologics and biosimilar CDMO services for US, EU, and SRA RoW markets. The revised Phase 1 capital expenditure is ₹300 crore, up from ₹150 crore.